Close Menu

NEW YORK — Avellino Labs said today that its Menlo Park, California facility has received CLIA certification, enabling the company to receive and process samples for its AvaGen test for keratoconus and corneal dystrophies.

AvaGen is a next-generation sequencing-based test designed to analyze 1,000 variants across 75 genes to determine the risk of keratoconus, as well as over 70 TGFBI mutations of the transforming growth factor beta induced — or TGFBI — gene for detecting the presence of corneal dystrophies.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A federal judge has ruled that drug companies, device manufacturers, and universities need to provide missing clinical data from hundreds of trials to a federal website, ScienceInsider reports.

A genetic analysis suggests red pandas might actually belong to two different species, New Scientist reports.

NPR reports that the US Centers for Disease Control and Prevention has fixed the problem with some of its SARS-CoV-2 testing kits.

In Nature this week: epigenetic factors that prevent healthy aging and more.

Mar
18
Sponsored by
Roche

This webinar will discuss data from a recent real-world comparison study evaluating performance of two cell-free DNA methodologies as first-line prenatal screens.

Mar
31
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.